Biotech Showcase at SCIpharm 2006
News May 04, 2006
A chance to hear from some of the emerging stars within the European biotechnology sector, the Biotechnology Showcase at SCIpharm 2006 gives potential investors and partners the opportunity to hear from some of biotech’s prominent SME’s.
The Scottish Enterprise development agency is assisting Scottish companies to participate in the Biotech Showcase, which takes place on Tuesday 16th May.
SCIpharm 2006 is an industry-led event organised by the Society of Chemical Industry (SCI), May 14-17 at the EICC, Edinburgh, Scotland.
The Biotechnology Showcase line up of speakers includes:
Dr Florian von der Mulbe, CureVac GmbH, Germany
Dr Richard Tennant-Eyles, VASTox Plc, UK
Dr Giuseppe Giardina, NiKem Research srl, Italy
Dr Fiona Adair, Haptogen Ltd, Scotland
Dr David Bunton, Biopta, Scotland
Dr Jan Vos, XstalBio Limited, Scotland
Dr Tim Allsopp, Stem Cell Sciences, Scotland
Dr Deborah O’Neil, NovaBiotics Ltd, Scotland
Dr Tom Shepherd, CXR Biosciences, Scotland
Dr Donald McPhail, AOX Therapeutics, Scotland
To maximise the effectiveness of attending SCIpharm, particularly for those attending the Biotechnology Showcase, proprietary meetings software is available via the SCIpharm website.
This allows attendees to pre-arrange meetings via a password protected programme. Registration and further conference programme details are available online.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.